Denali
We would like to show you a description here but the site won’t allow us.
Denali | Home
Neurodegenerative diseases are one of the largest medical challenges of our time. Denali Therapeutics is dedicated to defeating neurodegenerative and lysosomal storage diseases through rigorous therapeutic discovery and development.
Denali | Hunter Syndrome (MPS II) Clinical Program
Learn about Denali's Hunter Syndrom (MPS II) program. Hunter syndrome, or mucopolysaccharidosis type II (MPS II), is a rare progressively debilitating genetic disorder caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase (I2S)
Pipeline - Denali
Denali Therapeutics is dedicated to defeating neurodegenerative diseases through rigorous therapeutic discovery and development.
Denali
All legitimate Denali postings will be listed on our website: https://www.denalitherapeutics.com/careers. Denali will only contact you through Denali email …
Careers - Denali
Explore current job openings & get a general overview of life at Denali. See descriptions of unique programs including STEM, internships, & our postdoc program
Denali | Postdoc Program
Denali's postdoc program provides a cutting-edge training environment for candidates to explore highly translational research projects focused on mechanisms of neurodegeneration, novel biomarker pathways, and the blood-brain barrier.
Denali | Defeat Degeneration
Denali Therapeutics is dedicated to defeating neurodegenerative diseases through rigorous therapeutic discovery and development.
Denali Therapeutics Salt Lake City Drug Testing Policy
Denali Therapeutics Inc. (Denali) is committed to providing a safe, healthy, and productive workplace that is free from alcohol and unlawful drugs as classified under local, state, or federal laws while employees are working in select areas and performing specific job functions at Denali’s Salt Lake City (SLC) premises.
Denali | Alzheimer's Disease Clinical Program
Denali is committed to working towards the discovery of potential treatments for Alzheimer’s disease, a progressive neurodegenerative disorder. Currently Denali’s pipeline has several possible future treatments that are targeting various potential causes of Alzheimer’s disease.